Literature DB >> 24755858

Prevalence and risk factors for asymptomatic Clostridium difficile carriage.

Faisal Alasmari1, Sondra M Seiler2, Tiffany Hink2, Carey-Ann D Burnham3, Erik R Dubberke2.   

Abstract

BACKGROUND: Clostridium difficile infection (CDI) incidence has increased dramatically over the last decade. Recent studies suggest that asymptomatic carriers may be an important reservoir of C. difficile in healthcare settings. We sought to identify the prevalence and risk factors for asymptomatic C. difficile carriage on admission to the hospital.
METHODS: Patients admitted to Barnes-Jewish Hospital without diarrhea were enrolled from June 2010 through October 2011. Demographic information and healthcare and medication exposures 90 days prior to admission were collected. Stool specimens or rectal swabs were collected within 48 hours of admission and stored at -30°C until cultured. Clostridium difficile isolates were typed and compared with isolates from patients with CDI.
RESULTS: A stool/swab specimen was obtained for 259 enrolled subjects on admission. Two hundred four (79%) were not colonized, 40 (15%) had toxigenic C. difficile (TCD), and 15 (6%) had nontoxigenic C. difficile. There were no differences between TCD-colonized and -uncolonized subjects for age (mean, 56 vs 58 years; P = .46), comorbidities, admission from another healthcare facility (33% vs 24%; P = .23), or recent hospitalization (50% vs 50%; P = .43). There were no differences in antimicrobial exposures in the 90 days prior to admission (55% vs 56%; P = .91). Asymptomatic carriers were colonized with strains similar to strains from patients with CDI, but the relative proportions were different.
CONCLUSIONS: There was a high prevalence of TCD colonization on admission. In contrast to past studies, TCD colonization was not associated with recent antimicrobial or healthcare exposures. Additional investigation is needed to determine the role of asymptomatic TCD carriers on hospital-onset CDI incidence.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Clostridium difficile colonization; asymptomatic carrier; prevalence; risk factors

Mesh:

Year:  2014        PMID: 24755858      PMCID: PMC4133563          DOI: 10.1093/cid/ciu258

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  46 in total

1.  Low prevalence of nosocomial Clostridium difficile transmission, as determined by comparison of arbitrarily primed PCR and epidemiological data.

Authors:  M Wullt; M H Laurell
Journal:  J Hosp Infect       Date:  1999-12       Impact factor: 3.926

2.  Development and evaluation of a novel, semiautomated Clostridium difficile typing platform.

Authors:  Lars F Westblade; Robin R Chamberland; Duncan MacCannell; Rachel Collins; Erik R Dubberke; W Michael Dunne; Carey-Ann D Burnham
Journal:  J Clin Microbiol       Date:  2012-11-21       Impact factor: 5.948

3.  Clostridium difficile ribotype diversity at six health care institutions in the United States.

Authors:  Sheila Waslawski; Eugene S Lo; Sarah A Ewing; Vincent B Young; David M Aronoff; Susan E Sharp; Susan M Novak-Weekley; Arthur E Crist; W Michael Dunne; Joan Hoppe-Bauer; Michelle Johnson; Stephen M Brecher; Duane W Newton; Seth T Walk
Journal:  J Clin Microbiol       Date:  2013-04-03       Impact factor: 5.948

4.  Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission.

Authors:  Scott R Curry; Carlene A Muto; Jessica L Schlackman; A William Pasculle; Kathleen A Shutt; Jane W Marsh; Lee H Harrison
Journal:  Clin Infect Dis       Date:  2013-07-23       Impact factor: 9.079

5.  Asymptomatic Clostridium difficile colonization in a tertiary care hospital: admission prevalence and risk factors.

Authors:  Surbhi Leekha; Kimberly C Aronhalt; Lynne M Sloan; Robin Patel; Robert Orenstein
Journal:  Am J Infect Control       Date:  2013-05       Impact factor: 2.918

6.  Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

Authors:  L Kyne; M Warny; A Qamar; C P Kelly
Journal:  N Engl J Med       Date:  2000-02-10       Impact factor: 91.245

7.  Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.

Authors:  Amit S Chitnis; Stacy M Holzbauer; Ruth M Belflower; Lisa G Winston; Wendy M Bamberg; Carol Lyons; Monica M Farley; Ghinwa K Dumyati; Lucy E Wilson; Zintars G Beldavs; John R Dunn; L Hannah Gould; Duncan R MacCannell; Dale N Gerding; L Clifford McDonald; Fernanda C Lessa
Journal:  JAMA Intern Med       Date:  2013-07-22       Impact factor: 21.873

Review 8.  Burden of Clostridium difficile on the healthcare system.

Authors:  Erik R Dubberke; Margaret A Olsen
Journal:  Clin Infect Dis       Date:  2012-08       Impact factor: 9.079

9.  Diverse sources of C. difficile infection identified on whole-genome sequencing.

Authors:  Derrick W Crook; Mark H Wilcox; Tim E A Peto; A Sarah Walker; David W Eyre; Madeleine L Cule; Daniel J Wilson; David Griffiths; Alison Vaughan; Lily O'Connor; Camilla L C Ip; Tanya Golubchik; Elizabeth M Batty; John M Finney; David H Wyllie; Xavier Didelot; Paolo Piazza; Rory Bowden; Kate E Dingle; Rosalind M Harding
Journal:  N Engl J Med       Date:  2013-09-26       Impact factor: 91.245

10.  Microevolutionary analysis of Clostridium difficile genomes to investigate transmission.

Authors:  Xavier Didelot; David W Eyre; Madeleine Cule; Camilla L C Ip; M Azim Ansari; David Griffiths; Alison Vaughan; Lily O'Connor; Tanya Golubchik; Elizabeth M Batty; Paolo Piazza; Daniel J Wilson; Rory Bowden; Peter J Donnelly; Kate E Dingle; Mark Wilcox; A Sarah Walker; Derrick W Crook; Tim E A Peto; Rosalind M Harding
Journal:  Genome Biol       Date:  2012-12-21       Impact factor: 13.583

View more
  51 in total

1.  Ceftolozane-tazobactam activity against phylogenetically diverse Clostridium difficile strains.

Authors:  Mark D Gonzalez; Meghan A Wallace; Tiffany Hink; Erik R Dubberke; Carey-Ann D Burnham
Journal:  Antimicrob Agents Chemother       Date:  2015-08-17       Impact factor: 5.191

Review 2.  Recurrent Clostridium difficile infection and the microbiome.

Authors:  Rowena Almeida; Teklu Gerbaba; Elaine O Petrof
Journal:  J Gastroenterol       Date:  2015-07-08       Impact factor: 7.527

3.  Binary toxin and its clinical importance in Clostridium difficile infection, Belgium.

Authors:  T Pilate; J Verhaegen; M Van Ranst; V Saegeman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-08       Impact factor: 3.267

Review 4.  Probiotics for prevention of Clostridium difficile infection.

Authors:  John P Mills; Krishna Rao; Vincent B Young
Journal:  Curr Opin Gastroenterol       Date:  2018-01       Impact factor: 3.287

5.  Cirrhosis and C. difficile: A Deadly Duo?

Authors:  Stephen M Vindigni; Christina M Surawicz
Journal:  Dig Dis Sci       Date:  2015-10       Impact factor: 3.199

6.  Response to Matuchansky. [corrected].

Authors:  Ioannis M Zacharioudakis; Fainareti N Zervou; Elina Eleftheria Pliakos; Panayiotis D Ziakas; Eleftherios Mylonakis
Journal:  Am J Gastroenterol       Date:  2015-07       Impact factor: 10.864

7.  Canadian Public Health Laboratory Network position statement: Non-culture based diagnostics for gastroenteritis and implications for public health investigations.

Authors:  B Berenger; L Chui; A R Reimer; V Allen; D Alexander; M-C Domingo; D Haldane; L Hoang; P Levett; A MacKeen; D Marcino; C Sheitoyan-Pesant; G Zahariadis
Journal:  Can Commun Dis Rep       Date:  2017-12-07

Review 8.  Host response to Clostridium difficile infection: Diagnostics and detection.

Authors:  Elena A Usacheva; Jian-P Jin; Lance R Peterson
Journal:  J Glob Antimicrob Resist       Date:  2016-09-20       Impact factor: 4.035

9.  An Evaluation of Food as a Potential Source for Clostridium difficile Acquisition in Hospitalized Patients.

Authors:  Jennie H Kwon; Cristina Lanzas; Kimberly A Reske; Tiffany Hink; Sondra M Seiler; Kerry M Bommarito; Carey-Ann D Burnham; Erik R Dubberke
Journal:  Infect Control Hosp Epidemiol       Date:  2016-10-03       Impact factor: 3.254

Review 10.  Understanding Clostridium difficile Colonization.

Authors:  Monique J T Crobach; Jonathan J Vernon; Vivian G Loo; Ling Yuan Kong; Séverine Péchiné; Mark H Wilcox; Ed J Kuijper
Journal:  Clin Microbiol Rev       Date:  2018-03-14       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.